Abstract
Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs), isolated from discarded extra-embryonic tissue after birth, are promising candidate source of mesenchymal stem cells (MSCs). Apart from their prominent advantages in abundant supply, painless collection, and faster self-renewal, hUC-MSCs have shown the potencies to differentiate into a variety of cells of three germ layers (such as bone, cartilage, adipose, skeletal muscle, cardiomyocyte, endothelium, hepatocyte-like cluster, islet-like cluster, neuron, astrocyte and oligodendrocyte), to synthesize and secret a set of trophic factors and cytokines, to support the expansion and function of other cells (like hematopoietic stem cells, embryonic stem cells, natural killer cells, islet-like cell clusters, neurons and glial cells) , to migrate toward and home to pathological areas, and to be readily transfected with conventional methods. Two excellent previous reviews documenting the characteristics of this cell population with special emphasis on its niche, isolation, surface markers and primitive properties have been published recently. In this review, we will firstly give a brief introduction of this cell population, and subsequently dwell on the findings of differential capacities with emphasis on its therapeutic potentials.
Similar content being viewed by others
References
Nanaev, A. K., Kohnen, G., Milovanov, A. P., Domogatsky, S. P., & Kaufmann, P. (1997). Stromal differentiation and architecture of the human umbilical cord. Placenta, 18(1), 53–64.
Eyden, B. P., Ponting, J., Davies, H., Bartley, C., & Torgersen, E. (1994). Defining the myofibroblast: normal tissues, with special reference to the stromal cells of Wharton’s jelly in human umbilical cord. Journal of Submicroscopic Cytology and Pathology, 26(3), 347–355.
Kobayashi, K., Kubota, T., & Aso, T. (1998). Study on myofibroblast differentiation in the stromal cells of Wharton’s jelly: expression and localization of alpha-smooth muscle actin. Early Human Development, 51(3), 223–233.
Mitchell, K. E., Weiss, M. L., Mitchell, B. M., et al. (2003). Matrix cells from Wharton’s jelly form neurons and glia. Stem Cells, 21(1), 50–60.
Romanov, Y. A., Svintsitskaya, V. A., & Smirnov, V. N. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells, 21(1), 105–110.
Can, A., & Karahuseyinoglu, S. (2007). Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells, 25(11), 2886–2895.
Troyer, D. L., & Weiss, M. L. (2008). Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells, 26(3), 591–599.
Hyslop, L. A., Armstrong, L., Stojkovic, M., & Lako, M. (2005). Human embryonic stem cells: biology and clinical implications. Expert Reviews in Molecular Medicine, 7(19), 1–21.
Geeta, R., Ramnath, R. L., Rao, H. S., & Chandra, V. (2008). One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochemical and Biophysical Research Communications, 373(2), 258–264.
López-González, R., Knuckles, P., & Velasco, I. (2009). Transient Recovery in a Rat Model of Familial Amyotrophic Lateral Sclerosis after Transplantation of Motor Neurons Derived From Mouse Embryonic Stem Cells. Cell Transplantation, 18(10), 1171–1181.
Sharp, J., Frame, J., Siegenthaler, M., Nistor, G., & Keirstead, H. S. (2010). Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells, 28(1), 152–163.
Hatami, M., Mehrjardi, N. Z., Kiani, S., et al. (2009). Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. Cytotherapy, 11(5), 618–630.
Hicks, A. U., Lappalainen, R. S., Narkilahti, S., et al. (2009). Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. The European Journal of Neuroscience, 29(3), 562–574.
Pal, R. (2009). Embryonic stem (ES) cell-derived cardiomyocytes: a good candidate for cell therapy applications. Cell Biology International, 33(3), 325–336.
Jiang, J., Au, M., Lu, K., et al. (2007). Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells, 25(8), 1940–1953.
Wang, Y., Yates, F., Naveiras, O., Ernst, P., & Daley, G. Q. (2005). Embryonic stem cell-derived hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 102(52), 19081–6.
Ishii, T., Yasuchika, K., Machimoto, T., et al. (2007). Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Stem Cells, 25(12), 3252–3260.
Van Vranken, B.E., Rippon, H.J., Samadikuchaksaraei, A., Trounson, A.O., & Bishop, A.E. (2007). The differentiation of distal lung epithelium from embryonic stem cells. Curr Protoc Stem Cell Biol, Chapter 1, Unit 1G.1.
Riekstina, U., Muceniece, R., Cakstina, I., Muiznieks, I., & Ancans, J. (2008). Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions. Cytotechnology, 58(3), 153–162.
Gastens, M. H., Goltry, K., Prohaska, W., et al. (2007). Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy. Cell Transplantation, 16(7), 685–696.
Keyser, K. A., Beagles, K. E., & Kiem, H. P. (2007). Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplantation, 16(5), 555–562.
Roobrouck, V. D., Ulloa-Montoya, F., & Verfaillie, C. M. (2008). Self-renewal and differentiation capacity of young and aged stem cells. Experimental Cell Research, 314(9), 1937–1944.
Chang, P. L., Blair, H. C., Zhao, X., et al. (2006). Comparison of fetal and adult marrow stromal cells in osteogenesis with and without glucocorticoids. Connective Tissue Research, 47(2), 67–76.
Fan, C. G., Tang, F. W., Zhang, Q. J., et al. (2005). Characterization and neural differentiation of fetal lung mesenchymal stem cells. Cell Transplantation, 14(5), 311–321.
In’t Anker, P. S., Noort, W. A., Scherjon, S. A., et al. (2003). Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica, 88(8), 845–852.
Hu, Y., Liao, L., Wang, Q., et al. (2003). Isolation and identification of mesenchymal stem cells from human fetal pancreas. The Journal of Laboratory and Clinical Medicine, 141(5), 342–349.
Yu, M., Xiao, Z., Shen, L., & Li, L. (2004). Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not. British Journal Haematology, 124(5), 666–675.
Lu, F. Z., Fujino, M., Kitazawa, Y., et al. (2005). Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood. The Journal of Laboratory and Clinical Medicine, 146(5), 271–278.
Fan, C. G., Zhang, Q. J., & Han, Z. C. (2005). Neural differentiation of mesenchymal stem cells from umbilical cord. Chinese Journal of Neurosurgery, 21(7), 388–392.
Mareschi, K., Rustichelli, D., Comunanza, V., et al. (2009). Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels. Cytotherapy, 11(5), 534–547.
In’t Anker, P. S., Scherjon, S. A., Kleijburg-van der Keur, C., et al. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22(7), 1338–1345.
Bilic, G., Zeisberger, S. M., Mallik, A. S., Zimmermann, R., & Zisch, A. H. (2008). Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplantation, 17(8), 955–968.
Wang, H. S., Hung, S. C., Peng, S. T., et al. (2004). Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells, 22(7), 1330–1337.
Karahuseyinoglu, S., Cinar, O., Kilic, E., et al. (2007). Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells, 25(2), 319–331.
Schneider, R. K., Puellen, A., Kramann, R., et al. (2010). The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials, 31(3), 467–480.
Wang, L., Tran, I., Seshareddy, K., Weiss, M. L., & Detamore, M. S. (2009). A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Engineering. Part A, 15(8), 2259–2266.
Karahuseyinoglu, S., Kocaefe, C., Balci, D., Erdemli, E., & Can, A. (2008). Functional structure of adipocytes differentiated from human umbilical cord stroma-derived stem cells. Stem Cells, 26(3), 682–691.
Woodbury, D., Schwarz, E. J., Prockop, D. J., & Black, I. B. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of Neuroscience Research, 61(4), 364–370.
Fu, Y. S., Shih, Y. T., Cheng, Y. C., & Min, M. Y. (2004). Transformation of human umbilical mesenchymal cells into neurons in vitro. Journal of Biomedical Science, 11(5), 652–660.
Ma, L., Feng, X. Y., Cui, B. L., et al. (2005). Human umbilical cord Wharton’s Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. Chinese Medical Journal (English), 118(23), 1987–1993.
Ding, D. C., Shyu, W. C., Chiang, M. F., et al. (2007). Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiology of Disease, 27(3), 339–353.
Kadam, S. S., Tiwari, S., & Bhonde, R. R. (2009). Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord. In Vitro Cellular & Developmental Biology Animal, 45(1–2), 23–27.
Weiss, M. L., Medicetty, S., Bledsoe, A. R., et al. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson’s disease. Stem Cells, 24(3), 781–792.
Fu, Y. S., Cheng, Y. C., Lin, M. Y., et al. (2006). Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells, 24(1), 115–124.
Kadivar, M., Khatami, S., Mortazavi, Y., Shokrgozar, M. A., Taghikhani, M., & Soleimani, M. (2006). In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochemical and Biophysical Research Communications, 340(2), 639–647.
Koh, S. H., Kim, K. S., Choi, M. R., et al. (2008). Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Research, 1229, 233–248.
Lund, R. D., Wang, S., Lu, B., et al. (2007). Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells, 25(3), 602–611.
Hess, D. C., & Borlongan, C. V. (2008). Cell-based therapy in ischemic stroke. Expert Review of Neurotherapeutics, 8(8), 1193–1201.
Skvortsova, V. I., Gubskiy, L. V., Tairova, R. T., et al. (2008). Use of bone marrow mesenchymal (stromal) stem cells in experimental ischemic stroke in rats. Bulletin of Experimental Biology and Medicine, 145(1), 122–128.
Liao, W., Xie, J., Zhong, J., et al. (2009). Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation, 87(3), 350–359.
Liao, W., Zhong, J., Yu, J., et al. (2009). Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cellular Physiology and Biochemistry, 24(3–4), 307–316.
Deshpande, D. M., Kim, Y. S., Martinez, T., et al. (2006). Recovery from paralysis in adult rats using embryonic stem cells. Annals of Neurology, 60(1), 32–44.
Lim, J. H., Byeon, Y. E., Ryu, H. H., et al. (2007). Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. Journal of Veterinary Science, 8(3), 275–282.
Zhao, Z. M., Li, H. J., Liu, H. Y., et al. (2004). Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplantation, 13(2), 113–122.
Coutts, M., & Keirstead, H. S. (2008). Stem cells for the treatment of spinal cord injury. Experimental Neurology, 209(2), 368–377.
Yang, C. C., Shih, Y. H., Ko, M. H., Hsu, S. Y., Cheng, H., & Fu, Y. S. (2008). Transplantation of human umbilical mesenchymal stem cells from Wharton’s jelly after complete transection of the rat spinal cord. PLoS ONE, 3(10), e3336.
Zhang, L., Zhang, H. T., Hong, S. Q., Ma, X., Jiang, X. D., & Xu, R. X. (2009). Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection. Neurochemical Research, 34(11), 2030–2039.
Yasuhara, T., & Date, I. (2007). Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application. Cell Transplantation, 16(2), 125–132.
Zhang, S., Liu, X. Z., Liu, Z. L., et al. (2009). Stem cells modified by brain-derived neurotrophic factor to promote stem cells differentiation into neurons and enhance neuromotor function after brain injury. Chinese Journal of Traumatology, 12(4), 195–199.
Zimmet, P., Alberti, K. G., & Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature, 414, 782–787.
Bretzel, R. G., Browatzki, C. C., Schultz, A., et al. (1993). Clinical islet transplantation in diabetes mellitus-report of the Islet Transplant Registry and the Giessen Center experience. Diabet Stoffwechsel, 2, 378–390.
Shapiro, A. M., Lakey, J. R., Ryan, E. A., et al. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. The New England Journal of Medicine, 343, 230–238.
Lumelsky, N., Blondel, O., Laeng, P., et al. (2001). Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292, 1389–1394.
Ramiya, V. K., Maraist, M., Arfors, K. E., et al. (2000). Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Natural Medicines, 6, 278–282.
Yang, L., Li, S., Hatch, H., et al. (2002). In vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormoneproducing cells. Proceedings of the National Academy of Sciences of the United States of America, 99, 8078–8083.
Hori, Y., Gu, X., Xie, X., et al. (2005). Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Medicine, 2(4), e103.
Oh, S. H., Muzzonigro, T. M., Bae, S. H., et al. (2004). Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Laboratory Investigation, 84, 607–617.
Ende, N., Chen, R., & Reddi, A. S. (2004). Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochemical and Biophysical Research Communications, 325, 665–669.
Chao, K. C., Chao, K. F., Fu, Y. S., & Liu, S. H. (2008). Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS ONE, 3(1), e1451.
Lorenzini, S., Gitto, S., Grandini, E., Andreone, P., & Bernardi, M. (2008). Stem cells for end stage liver disease: how far have we got? World Journal of Gastroenterology, 14(29), 4593–4599.
Campard, D., Lysy, P. A., Najimi, M., & Sokal, E. M. (2008). Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology, 134(3), 833–848.
Zhang, Y. N., Lie, P. C., & Wei, X. (2009). Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells. Cytotherapy, 11(5), 548–558.
Zhao, Q., Ren, H., Li, X., et al. (2009). Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells. Cytotherapy, 11(4), 414–426.
Tsai, P. C., Fu, T. W., Chen, Y. M., et al. (2009). The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transplant, 15(5), 484–495.
Yan, Y., Xu, W., Qian, H., et al. (2009). Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver International, 29(3), 356–365.
Kadner, A., Hoerstrup, S. P., Tracy, J., et al. (2002). Human umbilical cord cells: a new cell source for cardiovascular tissue engineering. The Annals of Thoracic Surgery, 74(4), S1422–1428.
Kadner, A., Zund, G., Maurus, C., et al. (2004). Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. European Journal of Cardiothoracic Surgery, 25(4), 635–641.
Hoerstrup, S. P., Kadner, A., Breymann, C., et al. (2002). Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. The Annals of Thoracic Surgery, 74(1), 46–52.
Schmidt, D., Mol, A., Neuenschwander, S., et al. (2005). Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. European Journal of Cardiothoracic Surgery, 27(5), 795–800.
Sodian, R., Lueders, C., Kraemer, L., et al. (2006). Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. The Annals of Thoracic Surgery, 81(6), 2207–2216.
Breymann, C., Schmidt, D., & Hoerstrup, S. P. (2006). Umbilical cord cells as a source of cardiovascular tissue engineering. Stem Cell Reviews, 2(2), 87–92.
Pereira, W. C., Khushnooma, I., Madkaikar, M., & Ghosh, K. (2008). Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. Journal of Tissue Engineering and Regenerative Medicine, 2(7), 394–399.
Martin-Rendon, E., Sweeney, D., Lu, F., Girdlestone, J., Navarrete, C., & Watt, S. M. (2008). 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sanguinis, 95(2), 137–148.
Wu, K. H., Zhou, B., Lu, S. H., et al. (2007). In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. Journal of Cellular Biochemistry, 100(3), 608–616.
Conconi, M. T., Burra, P., Di Liddo, R., et al. (2006). CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. International Journal of Molecular Medicine, 18(6), 1089–1096.
Chen, M. Y., Lie, P. C., Li, Z. L., & Wei, X. (2009). Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Experimental Hematology, 37(5), 629–640.
Wang, S. H., Lin, S. J., Chen, Y. H., et al. (2009). Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), 816–822.
Li, N., Feugier, P., Serrurrier, B., et al. (2007). Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity. Experimental Hematology, 35(3), 507–515.
Kim, D. W., Chung, Y. J., Kim, T. G., Kim, Y. L., & Oh, I. H. (2004). Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood, 103(5), 1941–1948.
Lu, L. L., Liu, Y. J., Yang, S. G., et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91(8), 1017–1026.
Bakhshi, T., Zabriskie, R. C., Bodie, S., et al. (2008). Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture. Transfusion, 48(12), 2638–2644.
Friedman, R., Betancur, M., Boissel, L., Tuncer, H., Cetrulo, C., & Klingemann, H. (2007). Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biology of Blood and Marrow Transplantation, 13(12), 1477–1486.
Hao, M., Meng, H. X., Li, G., et al. (2009). Study of influence of umbilical cord mesenchymal stem cells on CD34+ cells in vivo homing in NOD/SCID. Zhonghua Xue Ye Xue Za Zhi, 30(2), 103–106.
Liu, M., Yang, S. G., Liu, P. X., et al. (2009). Comparative study of in vitro hematopoietic supportive capability of human mesenchymal stem cells derived from bone marrow and umbilical cord. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 17(5), 1294–1300.
Chao, K. C., Chao, K. F., Chen, C. F., & Liu, S. H. (2008). A novel human stem cell coculture system that maintains the survival and function of culture islet-like cell clusters. Cell Transplantation, 17(6), 657–664.
Boissel, L., Tuncer, H. H., Betancur, M., Wolfberg, A., & Klingemann, H. (2008). Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. Biology of Blood and Marrow Transplantation, 14(9), 1031–1038.
Skottman, H., & Hovatta, O. (2006). Culture conditions for human embryonic stem cells. Reproduction, 132(5), 691–698.
Hiroyama, T., Sudo, K., Aoki, N., et al. (2008). Human umbilical cord-derived cells can often serve as feeder cells to maintain primate embryonic stem cells in a state capable of producing hematopoietic cells. Cell Biology International, 32(1), 1–7.
Salgado, A. J., Fraga, J. S., Mesquita, A. R., Neves, N. M., Reis, R. L., & Sousa, N. (2009). Role of Human Umbilical Cord Mesenchymal Progenitors Conditioned Media in Neuronal/Glial Cell Densities. Viability and Proliferation. Stem Cells and Development. doi:10.1089/scd.2009.0279.
Nauta, A. J., & Fibbe, W. E. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood, 110(10), 3499–3506.
Weiss, M. L., Anderson, C., Medicetty, S., et al. (2008). Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells, 26(11), 2865–2874.
Yoo, K. H., Jang, I. K., Lee, M. W., et al. (2009). Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cellular Immunology, 259(2), 150–156.
Cho, P. S., Messina, D. J., Hirsh, E. L., et al. (2008). Immunogenicity of umbilical cord tissue derived cells. Blood, 111(1), 430–438.
Kumar, S., Chanda, D., & Ponnazhagan, S. (2008). Therapeutic potential of genetically modified mesenchymal stem cells. Gene Therapy, 15(10), 711–715.
Fritz, V., & Jorgensen, C. (2008). Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Current Stem Cell Research & Therapy, 3(1), 32–42.
Baksh, D., Yao, R., & Tuan, R. S. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 25(6), 1384–1392.
Rachakatla, R. S., Pyle, M. M., Ayuzawa, R., et al. (2008). Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs. Cancer Investigation, 26(7), 662–670.
Rachakatla, R. S., Marini, F., Weiss, M. L., Tamura, M., & Troyer, D. (2007). Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Therapy, 14(10), 828–835.
Chen, X. L., Dong, C. L., Feng, X. M., et al. (2009). Expression of human factor IX in retrovirus-transfected human umbilical cord tissue derived mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 17(1), 184–187.
Lee, D. H., Ahn, Y., Kim, S. U., et al. (2009). Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clinical Cancer Research, 15(15), 4925–4934.
Stolzing, A., Jones, E., McGonagle, D., & Scutt, A. (2008). Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mechanisms of Ageing and Development, 129(3), 163–173.
Zhou, S., Greenberger, J. S., Epperly, M. W., et al. (2008). Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell, 7(3), 335–343.
Rao, M. S., & Mattson, M. P. (2001). Stem cells and aging: expanding the possibilities. Mechanisms of Ageing and Development, 122(7), 713–734.
Petsa, A., Gargani, S., Felesakis, A., Grigoriadis, N., & Grigoriadis, I. (2009). Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications. In Vitro Cellular & Developmental Biology. Animal, 45(10), 573–576.
Shetty, P., Cooper, K., & Viswanathan, C. (2010). Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian Journal Transfusion Science, 4(1), 14–24.
Han, Z. C. (2009). Umblical cord mesenchymal stem cells (UC-MSC: biology, banking and clinical applications). Bulletin de l'Académie Nationale de Médecine, 193(3), 545–547. discussion 547.
Secco, M., Zucconi, E., Vieira, N. M., et al. (2008). Mesenchymal stem cells from umbilical cord: do not discard the cord! Neuromuscular Disorders, 18(1), 17–18.
Secco, M., Zucconi, E., Vieira, N. M., et al. (2008). Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells, 26(1), 146–150.
Xu, J., Liao, W., Gu, D., et al. (2009). Neural ganglioside GD2 identifies a subpopulation of mesenchymal stem cells in umbilical cord. Cellular Physiology and Biochemistry, 23(4–6), 415–424.
Liang, J., Gu, F., Wang, H., et al. (2010). Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nature Reviews Rheumatology. doi:10.1038/nrrheum.2010.80.
Sun, L., Wang, D., Liang, J., et al. (2010). Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis and Rheumatism. doi:10.1177/1352458509104590.
Liang, J., Zhang, H., Hua, B., et al. (2009). Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Multiple Sclerosis, 15(5), 644–646.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors declare no potential conflicts of interest.
Rights and permissions
About this article
Cite this article
Fan, CG., Zhang, Qj. & Zhou, Jr. Therapeutic Potentials of Mesenchymal Stem Cells Derived from Human Umbilical Cord. Stem Cell Rev and Rep 7, 195–207 (2011). https://doi.org/10.1007/s12015-010-9168-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-010-9168-8